CD274 and non-small cell lung carcinoma: In contrast to previous studies, we developed a weakly supervised DL-based quantification of PD-L1 status in IHC images from patients with non–small cell lung cancer (NSCLC) and evaluated it in a cohort of patients with solid tumors, all of them treated with immunotherapy.